Neurophth Biotechnology picks up $61.9m Series B

Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing.

Neurophth Biotechnology Ltd., a genetic medicines company, has raised $61.9 million in Series B financing. Guofang Capital and InnoVision Capital led the round.

Source: Press Release